Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06633250

Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy.

Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy: a Randomized Nutritional Clinical Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
104 (estimated)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
8 Months
Healthy volunteers
Not accepted

Summary

The main purpose of this study is to demonstrate that the growth of infants fed with the Test Formula is non-inferior those fed with the Control Formula. The study will also evaluate the gastrointestinal tolerance, quatliy of life and acceptability of the new rice protein-based formula in infants with cow's milk protein allergy (CMPA).

Conditions

Interventions

TypeNameDescription
OTHERTest FormulaHydrolyzed rice protein formula
OTHERControl FormulaCommercially available extensively hydrolyzed cow's milk formula

Timeline

Start date
2024-10-25
Primary completion
2026-08-01
Completion
2026-08-01
First posted
2024-10-09
Last updated
2025-12-26

Locations

19 sites across 3 countries: Germany, Italy, Poland

Source: ClinicalTrials.gov record NCT06633250. Inclusion in this directory is not an endorsement.

Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants Wi (NCT06633250) · Clinical Trials Directory